VWR International
Global distributor of laboratory, life-science, healthcare and research products.
Last updated August 27, 2026
AI crawler reads
No AI crawler has read this profile since Oct 28, 2026.
Overview
VWR International is a United States-based distributor of laboratory and research products operating under the Avantor group. Its business supplies chemicals, reagents, laboratory consumables, instruments, equipment, safety products and related services to organizations that conduct scientific, medical and industrial work. Customers have included government laboratories, pharmaceutical and biotechnology companies, academic institutions, healthcare organizations, electronics manufacturers and other industrial users. In addition to general laboratory distribution, the business has developed capabilities in cleanroom supplies, workplace safety, clinical-trial support and education-focused science products. The company traces its origins to 1852, when John Taylor established the John Taylor Company to sell mining and laboratory products. Over more than a century and a half, the business passed through several corporate combinations and name changes as it moved progressively toward laboratory and chemical distribution. In 1902, it was acquired by F. W. Braun and incorporated into the F. W. Braun Corporation. The subsequent formation of Braun-Knecht-Heimann, followed by its acquisition by George Van Waters and Nat Rogers, connected the business to Van Waters and Rogers, a chemical-distribution company founded by the two purchasers in 1924. The resulting corporate lineage ultimately produced the VWR organization. The company expanded through acquisitions and portfolio development. Its education-related operations included Science Kit, Boreal Laboratories and catalog assets obtained from Edmund Scientific Corporation. VWR also acquired Ward's Science and Sargent-Welch Scientific Company, Baxter's Industrial division, AMRESCO, BioExpress, Therapak, MESM, EPL Archives and Seastar Chemicals at different points in its development. These transactions broadened its offering beyond conventional laboratory consumables into biochemicals, molecular-biology materials, medical convenience kits, clinical-trial supplies, laboratory archiving and specialized chemicals. VWR's ownership structure changed several times. The VWR United Corporation became Univar Corporation in 1974; the Univar and VWR businesses were separated in 1986. Merck KGaA later acquired VWR and combined it with Merck Eurolab, creating a larger international laboratory-distribution operation. In 2004, VWR became a limited partnership controlled by Clayton, Dubilier & Rice, and in 2007 it was sold to Madison Dearborn Partners. The company moved its world headquarters to Radnor, Pennsylvania, in 2010. VWR subsequently returned to the public markets in 2014, but its public-company period ended when Avantor agreed to acquire it in 2017. Avantor completed the transaction on November 21, 2017, for cash consideration of $33.25 per VWR share and an announced enterprise value of approximately $6.4 billion. Today, VWR is best understood as a major operating brand and distribution platform within Avantor rather than as an independent listed company. Its role is to connect manufacturers of scientific products with laboratories and other professional users through catalogs, digital ordering, logistics, technical support and specialized supply-chain services. The brand's value proposition centers on breadth of assortment, dependable availability, compliance-oriented distribution and support for recurring laboratory purchasing. Its current status, exact geographic footprint and product architecture may vary as Avantor integrates VWR operations with its broader life-science portfolio.
History
VWR International's corporate history begins in 1852, when John Taylor founded the John Taylor Company to sell mining and laboratory products. Although the original enterprise served more than one specialized market, its later development increasingly concentrated on scientific and laboratory customers. In 1902, the company was purchased by F. W. Braun and merged into the F. W. Braun Corporation. In 1908, Braun departed that organization and formed Braun-Knecht-Heimann with Gustav Knecht and Richard Heimann. George Van Waters and Nat Rogers acquired Braun-Knecht-Heimann in 1950. Three years later, they purchased the F. W. Braun Corporation and combined it with Van Waters and Rogers, the chemical-distribution company they had founded in 1924. This sequence of mergers established much of the corporate lineage that later became VWR. The organization continued to change form during the second half of the twentieth century. In 1974, VWR United Corporation became Univar Corporation. The Univar and VWR businesses were separated in 1986, restoring VWR as a distinct corporate operation. The company expanded its product and customer base through acquisitions, including Ward's Science and Sargent-Welch Scientific Company in 1989 and Baxter's Industrial division in 1995. VWR also developed an education-oriented group, commonly referred to as VWR Education, which included Science Kit, Boreal Laboratories and catalog operations acquired from Edmund Scientific Corporation in 2001. Merck KGaA provided much of the capital associated with the Baxter transaction and later acquired VWR. Merck combined VWR with Merck Eurolab, creating a broader international laboratory-distribution business. In 2004, VWR became a limited partnership controlled by Clayton, Dubilier & Rice. CD&R sold the company to Madison Dearborn Partners in 2007. VWR moved its world headquarters to Radnor, Pennsylvania, in 2010, reinforcing the location that remains associated with the brand. During the 2010s, VWR pursued a combination of geographic expansion, product specialization and public-market financing. It acquired AMRESCO in 2011, adding biochemicals and reagents for molecular biology, histology and related research and production applications. It acquired BioExpress later in 2011, broadening its laboratory-supply distribution activities. The transactions also led to concerns about concentration in the laboratory-supplies market, particularly in relation to Thermo Fisher Scientific. VWR went public in October 2014. The offering reportedly raised $536 million and gave the company a valuation close to $5 billion. It continued to expand its specialist capabilities, acquiring Therapak in January 2016 and MESM in April 2017. Therapak added medical convenience-kit assembly and distribution, while MESM supplied laboratory and medical equipment for clinical trials. VWR also acquired EPL Archives and Seastar Chemicals in 2017. The company's independent public-company period ended in 2017. On May 5 of that year, Avantor announced an agreement to acquire VWR for $33.25 in cash per common share, representing an announced enterprise value of about $6.4 billion. Avantor completed the acquisition on November 21, 2017. VWR therefore became part of Avantor's life-science tools and services business rather than continuing as a separately listed company. VWR's current identity is that of an operating brand and distribution network within Avantor. Its historical breadth includes chemicals, reagents, instruments, consumables, safety and cleanroom products, education supplies, clinical materials and specialized logistics. The business serves research laboratories, pharmaceutical and biotechnology companies, government agencies, universities, healthcare users and industrial customers. Its strategic importance lies less in manufacturing a single signature product than in aggregating a wide range of scientific goods and making them available through catalog, digital-commerce, fulfillment and supply-chain services.
- 2017
Avantor announces and completes acquisition
[1]Avantor announced its acquisition of VWR in May and completed the transaction on November 21.
- 2016
Therapak acquisition
[1]VWR acquired Therapak Corporation, adding medical convenience-kit assembly and distribution.
- 2014
Initial public offering
[1]VWR completed an initial public offering in October 2014.
- 2011
AMRESCO and BioExpress acquisitions
[1]VWR acquired AMRESCO and BioExpress, expanding its biochemical, reagent and laboratory-distribution capabilities.
- 2010
World headquarters moves to Radnor
[1]VWR moved its world headquarters to Radnor, Pennsylvania.
- 2007
Madison Dearborn Partners acquires VWR
[1]CD&R sold VWR to Madison Dearborn Partners.
- 2004
VWR becomes a CD&R-controlled limited partnership
[1]Clayton, Dubilier & Rice took control of VWR through a limited-partnership structure.
- 2001
Expansion of education catalog operations
[1]VWR acquired catalog operations from Edmund Scientific Corporation, adding to its education-oriented portfolio.
- 1995
Acquisition of Baxter's Industrial division
[1]VWR completed its purchase of Baxter's Industrial division, substantially increasing the scale of its distribution business.
- 1989
Acquisition of Ward's Science and Sargent-Welch
[1]VWR acquired Ward's Science and Sargent-Welch Scientific Company, strengthening its education and laboratory-products activities.
Products and positioning
A broad-line, global laboratory and life-science distributor combining catalog scale, procurement convenience, logistics and technical support for professional research, healthcare, education, government and industrial customers.
Laboratory chemicals
Laboratory chemicals and solvents
VWR distributes a broad range of laboratory chemicals, solvents and related materials used in analytical testing, synthesis, sample preparation and routine research. The offering supports academic, industrial, pharmaceutical, biotechnology and government laboratories. As a distributor, VWR's role includes sourcing, catalog management, packaging, fulfillment and compliance-oriented handling rather than dependence on one proprietary chemical formulation.
Life-science reagents · 2011
Biochemicals and molecular-biology reagents
Through its distribution activities and the addition of businesses such as AMRESCO, VWR supplies biochemicals and reagents used in molecular biology, histology, research and production. These materials serve workflows that require specialized research inputs, including preparation, analysis and biological experimentation.
Laboratory supplies
Laboratory consumables
The VWR catalog includes recurring-use laboratory consumables and general supplies used in sample handling, storage, measurement, preparation and daily laboratory operations. This category is central to the company's broad-line distribution model, allowing customers to consolidate purchases from multiple manufacturers through a single supplier.
Laboratory equipment
Scientific instruments and equipment
VWR distributes laboratory instruments and equipment for research, testing and production environments. The range complements consumables and chemicals by providing customers with access to equipment procurement, supporting products and related supply-chain services through the same distribution channel.
Contamination control and safety
Cleanroom and safety supplies
VWR serves cleanroom and workplace-safety requirements with products intended to support contamination control, laboratory protection and regulated working environments. These offerings extend the business beyond ordinary laboratory consumables into pharmaceutical, electronics, healthcare and industrial settings where controlled environments and worker protection are important.
Clinical and medical supplies · 2016
Clinical-trial and medical convenience kits
The acquisition of Therapak expanded VWR into the assembly and distribution of medical convenience kits. This capability supports healthcare and clinical-research workflows and added kit-based fulfillment to VWR's existing laboratory distribution model.
Education supplies
Education science products
VWR's education-oriented operations have included Science Kit, Boreal Laboratories, Ward's Science, Sargent-Welch Scientific Company and catalog assets from Edmund Scientific Corporation. These products support science teaching, demonstrations and educational laboratory activities rather than only professional research.
Controversies
2010
Brisbane distribution-center closure and labor dispute
VWR's decision to close a unionized distribution center in Brisbane, California and move operations to a non-unionized facility in Visalia became a labor controversy. Accounts cited disagreements concerning union recognition, pay levels and contract negotiations involving material handlers at the receiving site.
Brand decisions
2017
Avantor acquisitionM&ABackground
Avantor sought to expand its life-science tools and services platform through the purchase of VWR, a large laboratory-distribution business.
Action taken
Avantor agreed to acquire VWR for $33.25 in cash per VWR common share and completed the transaction on November 21, 2017.
Aftermath
VWR ceased to operate as an independent listed company and became an operating brand within Avantor.
Announced enterprise value. Approximately $6.4 billion (2017 acquisition announcement)
2014
Initial public offeringOtherBackground
After years of private ownership and corporate restructuring, VWR pursued access to public equity markets.
Action taken
VWR completed an initial public offering in October 2014.
Aftermath
The transaction made VWR a publicly traded company until its acquisition by Avantor in 2017.
IPO proceeds. $536 million raised (October 2014)
2010
Relocation of Brisbane distribution operationsStrategyBackground
VWR operated a unionized distribution center in Brisbane, California, while seeking to reorganize the relevant distribution footprint.
Action taken
The company closed the Brisbane facility and moved operations to a non-unionized site in Visalia, California.
Aftermath
The move led to labor criticism and later disputes over organizing rights, compensation and contract negotiations at the Visalia facility.
Recent events
- 2017
VWR expands through MESM, EPL Archives and Seastar Chemicals acquisitions[1]
M&A
VWR acquired MESM, a supplier of laboratory and medical equipment for clinical trials, and also acquired EPL Archives and Seastar Chemicals earlier in the year.
- 2017
Avantor announces acquisition of VWR[1]
M&A
Avantor announced an agreement to purchase VWR for $33.25 in cash per VWR common share, with an announced enterprise value of approximately $6.4 billion.
- 2017
Avantor completes VWR acquisition[1]
M&A · Leadership change
Avantor completed its acquisition of VWR on November 21, 2017, ending VWR's status as an independent public company and placing the brand within Avantor's life-science platform.
- 2016
VWR acquires Therapak[1]
M&A
VWR acquired Therapak Corporation, an assembler and distributor of medical convenience kits with operations in the United States, the United Kingdom and the Czech Republic.
- 2014
VWR completes initial public offering[1]
Other
VWR's initial public offering raised approximately $536 million and valued the company at close to $5 billion according to contemporary reporting summarized in the company's reference history.
- 2011
VWR acquires AMRESCO[1]
M&A
VWR acquired AMRESCO, expanding its portfolio of biochemicals, reagents and related products used in molecular biology, histology, research and production.
- 2011
VWR acquires BioExpress[1]
M&A · Regulation
VWR acquired BioExpress, formerly known as ISC BioExpress. The transaction increased VWR's presence in laboratory-supply distribution and prompted discussion about concentration in the sector alongside Thermo Fisher Scientific.
Sources2 sources
Cite this profile: Cite the canonical profile. /brand-wiki/vwr-international · Editorial policy · How profiles are compiled